This role is accountable for end-to-end disease area translational science to inform therapy area and program level biomarker strategies from preclinical to launch.
Base: $189,750 to $316,250 (US specific locations); Bonus/Equity: Annual bonus and share-based long term incentive program; Benefits: Health care, insurance, retirement, paid leave
Must-have
Nice-to-have
Not specified